LONDON As expected Celoxica Holdings has been admiited to the Alternative Investment Market (AIM) of the London Stock Exchange. Dealings in the shares commenced today at 8.00am, trading under the symbol CXA.
Arbuthnot Securities is the Celoxica's nominated adviser and broker has placed 19,424,000 new ordinary shares with institutional investors, raising £5.3 million pounds (net of expenses). The new shares placed represent 37.7% of the company's enlarged issued share capital and none of the company's existing shareholders (including directors) sold any shares linked to the listing. Investors in Celoxica include Advent, Cazenove, Quester, Intel, Xilinx, Wind River and Creative.
The company, based in Abingdon, Oxfordshire, was established in the 1990s to further develop and commercialise electronic system level (ESL) design technology created at The University of Oxford. The technology now provides a more rapid and efficient way of designing applications in silicon chips by exploiting novel electronic system level design techniques, languages and tools.
Celoxica has licensed approximately 400 commercial seats of its design tools, across a range of industries: military & aerospace (to such organisations as Boeing, Lockheed Martin and NASA); automotive (Fujitsu Ten); consumer electronics (Canon and Toshiba); security (Tadiran, L3 Communications and HiEnergy); imaging (Olympus, FujiFilm); and high performance computing (Silicon Graphics, Cray and 454 Corporation.)